Indication
Postural Orthostatic Tachycardia Syndrome
11 clinical trials
12 products
2 drugs
Clinical trial
Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of Efgartigimod in Adult Patients With Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (PC-POTS) Who Completed Study ARGX-113-2104Status: Recruiting, Estimated PCD: 2025-05-01
Product
EfgartigimodClinical trial
A Pilot Study of Low Dose Naltrexone Use in Patients With Postural Orthostatic Tachycardia SyndromeStatus: Not yet recruiting, Estimated PCD: 2028-06-01
Product
NaltrexoneProduct
Microcrystalline celluloseClinical trial
Pathophysiology of Orthostatic IntoleranceStatus: Recruiting, Estimated PCD: 2025-12-01
Product
Intrinsic Heart RateClinical trial
A Phase 2 Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Adult Patients With Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)Status: Completed, Estimated PCD: 2024-04-18
Drug
VarlilumabClinical trial
Compression Garments in the Community With POTSStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Comparative Cohort Study of Post-acute COVID-19 Infection With a Nested, Randomized Controlled Trial of Ivabradine for Those With Postural Orthostatic Tachycardia Syndrome.Status: Recruiting, Estimated PCD: 2024-09-01
Product
IvabradineProduct
phenylephrineProduct
isoproterenolClinical trial
An Interventional, Double-Blinded, 2-Arm Study to Investigate the Efficacy of Orally Administered Nirmatrelvir/Ritonavir Compared With Placebo/Ritonavir in Non-hospitalized Adult Participants Suffering From Post-COVIDStatus: Recruiting, Estimated PCD: 2024-01-31
Product
Placebo/ritonavirClinical trial
Using Mirabegron to Increase Blood Pressure in Patients With Postural Orthostatic Tachycardia SyndromeStatus: Recruiting, Estimated PCD: 2025-11-21
Product
MirabegronClinical trial
A Randomized, Controlled, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of Intravenous Iron Sucrose in Patients With Non-anemic Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS)Status: Withdrawn, Estimated PCD: 2023-05-01
Product
SucroseClinical trial
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail ElderlyStatus: Completed, Estimated PCD: 2023-07-18
Product
Antihypertensive Agents